140 related articles for article (PubMed ID: 10655778)
1. [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].
Konishi T
Yakugaku Zasshi; 2000 Jan; 120(1):1-15. PubMed ID: 10655778
[TBL] [Abstract][Full Text] [Related]
2. Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.
Takahashi M; Konishi T; Maeda Y; Matsugu Y; Akazawa F; Eto T; Okajima M; Uchida K; Masaoka Y; Okada K
Gut; 1993 Jun; 34(6):823-8. PubMed ID: 8314517
[TBL] [Abstract][Full Text] [Related]
3. Basic studies on ursodeoxycholyl-para-aminobenzoic acid for evaluation of intestinal microflora.
Takahashi M; Maeda Y; Tashiro H; Akazawa F; Okajima M; Yoshioka S; Matsugu Y; Toyota K; Masaoka Y
Scand J Gastroenterol; 1991 Jun; 26(6):577-88. PubMed ID: 1862298
[TBL] [Abstract][Full Text] [Related]
4. Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.
Konishi T; Takahashi M; Ohta S
Biol Pharm Bull; 1997 Apr; 20(4):370-5. PubMed ID: 9145212
[TBL] [Abstract][Full Text] [Related]
5. Basic studies on N''-ursodeoxycholyldiethylenetriamine-N,N,N'-triacetic acid for the dissolution of calcified gallstones.
Takahashi M; Konishi T; Maeda Y; Fukuzawa M; Nishida T; Ohya T; Katayama K; Kakehi N; Sakakura H; Takagi A; Maeda M; Ohama H
Biol Pharm Bull; 1998 Jun; 21(6):551-7. PubMed ID: 9657036
[TBL] [Abstract][Full Text] [Related]
6. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
Maeda Y; Takahashi M
J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732
[TBL] [Abstract][Full Text] [Related]
7. A new simple test for evaluation of intestinal bacteria.
Takahashi M; Maeda Y; Tashiro H; Eto T; Goto T; Sanada O
World J Surg; 1990; 14(5):628-34; discussion 635. PubMed ID: 2238664
[TBL] [Abstract][Full Text] [Related]
8. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
Maeda Y; Takahashi M; Tashiro H; Akazawa F
J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016
[TBL] [Abstract][Full Text] [Related]
9. [The ursodeoxycholic acid-p-aminobenzoic acid test in the diagnosis of small bowel bacterial overgrowth syndrome].
Kiss Z; Wölfling J; Csáti S; Nagy F; Lonovics J; Schneider G
Orv Hetil; 1997 May; 138(20):1255-8. PubMed ID: 9244859
[TBL] [Abstract][Full Text] [Related]
10. The ursodeoxycholic acid-p-aminobenzoic acid deconjugation test, a new tool for the diagnosis of bacterial overgrowth syndrome.
Kiss ZF; Wölfling J; Csáti S; Nagy F; Wittmann T; Schneider G; Lonovics J
Eur J Gastroenterol Hepatol; 1997 Jul; 9(7):679-82. PubMed ID: 9262976
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth.
Maeda Y; Murakami T
Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830173
[TBL] [Abstract][Full Text] [Related]
12. Drug elimination function of rat small intestine: metabolism and intraluminal excretion.
Yasuhara M; Kurosaki Y; Kimura T; Sezaki H
Biochem Pharmacol; 1984 Oct; 33(20):3131-6. PubMed ID: 6333241
[TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.
Walker S; Rudolph G; Raedsch R; Stiehl A
Gastroenterology; 1992 Mar; 102(3):810-5. PubMed ID: 1537519
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.
Narisawa T; Fukaura Y; Takeba N; Nakai K
Jpn J Cancer Res; 2002 Feb; 93(2):143-50. PubMed ID: 11856477
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
Batta AK; Tint GS; Xu G; Shefer S; Salen G
J Lipid Res; 1998 Aug; 39(8):1641-6. PubMed ID: 9717724
[TBL] [Abstract][Full Text] [Related]
16. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
17. Absorption, biliary excretion, and metabolism of a new cholelitholytic agent, ursodeoxycholyl N-carboxymethylglycine and its esters in rats.
Hatono S; Yoshida H; Matsunami M; Ide Y; Matsuda K; Yatsunami T; Fuwa T; Kihira K; Kuramoto T; Hoshita T
J Pharmacobiodyn; 1991 Oct; 14(10):561-6. PubMed ID: 1818097
[TBL] [Abstract][Full Text] [Related]
18. A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon.
Asciutti S; Castellani D; Nardi E; Morelli O; Clementi M; Chistolini F; Gentili G; Setchell KD; O'Connell N; Pellicciari R; Clerici C
Anticancer Res; 2009 Dec; 29(12):4971-9. PubMed ID: 20044604
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats.
Ventura P; Panini R; Montosi G; Garuti C; Vandelli M; Brunetti G; Tauschel H; Pietrangelo A; Salvioli G
Pharmacology; 2001 Feb; 62(2):107-12. PubMed ID: 11174081
[TBL] [Abstract][Full Text] [Related]
20. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
